These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18053706)

  • 1. Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk.
    Shen J; Gammon MD; Terry MB; Teitelbaum SL; Eng SM; Neugut AI; Santella RM
    Eur J Cancer; 2008 Mar; 44(5):710-7. PubMed ID: 18053706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk.
    Crew KD; Gammon MD; Terry MB; Zhang FF; Zablotska LB; Agrawal M; Shen J; Long CM; Eng SM; Sagiv SK; Teitelbaum SL; Neugut AI; Santella RM
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2033-41. PubMed ID: 17932351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk.
    Terry MB; Gammon MD; Zhang FF; Eng SM; Sagiv SK; Paykin AB; Wang Q; Hayes S; Teitelbaum SL; Neugut AI; Santella RM
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2053-8. PubMed ID: 15598760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk.
    Shen J; Gammon MD; Terry MB; Wang L; Wang Q; Zhang F; Teitelbaum SL; Eng SM; Sagiv SK; Gaudet MM; Neugut AI; Santella RM
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):336-42. PubMed ID: 15734955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH-DNA adducts to breast cancer risk.
    Shen J; Terry MB; Gammon MD; Gaudet MM; Teitelbaum SL; Eng SM; Sagiv SK; Neugut AI; Santella RM
    Breast Cancer Res Treat; 2006 Sep; 99(1):1-7. PubMed ID: 16752224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers.
    Pavanello S; Pulliero A; Siwinska E; Mielzynska D; Clonfero E
    Carcinogenesis; 2005 Jan; 26(1):169-75. PubMed ID: 15471894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk.
    McCarty KM; Santella RM; Steck SE; Cleveland RJ; Ahn J; Ambrosone CB; North K; Sagiv SK; Eng SM; Teitelbaum SL; Neugut AI; Gammon MD
    Environ Health Perspect; 2009 Apr; 117(4):552-8. PubMed ID: 19440493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer.
    Tang D; Cho S; Rundle A; Chen S; Phillips D; Zhou J; Hsu Y; Schnabel F; Estabrook A; Perera FP
    Breast Cancer Res Treat; 2002 Sep; 75(2):159-66. PubMed ID: 12243508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.
    Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q
    Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer.
    Rundle A; Tang D; Hibshoosh H; Estabrook A; Schnabel F; Cao W; Grumet S; Perera FP
    Carcinogenesis; 2000 Jul; 21(7):1281-9. PubMed ID: 10874004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study.
    White AJ; Chen J; McCullough LE; Xu X; Cho YH; Teitelbaum SL; Neugut AI; Terry MB; Hibshoosh H; Santella RM; Gammon MD
    Cancer Causes Control; 2015 Dec; 26(12):1791-802. PubMed ID: 26407953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.
    Zhu Y; Lai M; Yang H; Lin J; Huang M; Grossman HB; Dinney CP; Wu X
    Carcinogenesis; 2007 Mar; 28(3):698-703. PubMed ID: 17052994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of XPC polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients.
    Yang X; Liu D; Wu H; Kang H; Pang H; Huang D; Sha X; Wang E; Wang Z; Wei M
    Cancer Sci; 2012 Jul; 103(7):1207-14. PubMed ID: 22519360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of XPC gene polymorphisms with breast cancer risk].
    Wu YY; Ma XY; Yao KY; Li QL; Chen K
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 May; 40(3):252-8. PubMed ID: 21671483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts.
    Gammon MD; Santella RM; Neugut AI; Eng SM; Teitelbaum SL; Paykin A; Levin B; Terry MB; Young TL; Wang LW; Wang Q; Britton JA; Wolff MS; Stellman SD; Hatch M; Kabat GC; Senie R; Garbowski G; Maffeo C; Montalvan P; Berkowitz G; Kemeny M; Citron M; Schnabel F; Schuss A; Hajdu S; Vinceguerra V
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):677-85. PubMed ID: 12163319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of DNA repair gene XPC Ala499Val (rs2228000 C>T) and Lys939Gln (rs2228001 A>C) polymorphisms with the risk of chronic myeloid leukemia: A case-control study in a South Indian population.
    Lakkireddy S; Aula S; Kapley A; Gundeti S; Kutala VK; Jamil K
    J Gene Med; 2021 Jul; 23(7):e3339. PubMed ID: 33829606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of GSTM1 null and low repair XPC PAT+ on anti-B[a]PDE-DNA adduct in mononuclear white blood cells of subjects low exposed to PAHs through smoking and diet.
    Pavanello S; Pulliero A; Clonfero E
    Mutat Res; 2008 Feb; 638(1-2):195-204. PubMed ID: 18035379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation of TP53, polycyclic aromatic hydrocarbon-related exposures, and breast cancer risk among women on Long Island, New York.
    Gaudet MM; Gammon MD; Bensen JT; Sagiv SK; Shantakumar S; Teitelbaum SL; Eng SM; Neugut AI; Santella RM
    Breast Cancer Res Treat; 2008 Mar; 108(1):93-9. PubMed ID: 17624591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.